GOTTWALD JOHN D sold $284K of TG (indirect holdings)

GOTTWALD JOHN D sold 35,507 indirectly-held shares of TREDEGAR CORP (TG) at $8.00 ($0.28M total) on 2026-10-16.

Original reporting
SEC EDGAR · GOTTWALD JOHN D
Published Oct 20, 2026, 4:54 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 4:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TG
Bearish
medium confidence
Mentioned
$TG
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TGBearishLow
01

Why it matters

The disclosed sale may prompt short‑term price adjustment but is unlikely to drive significant moves.

02

Market read

A routine insider sale with modest dollar value; limited trading relevance.

03

What to watch

Potential upcoming corporate actions or earnings could amplify the effect of this insider sell.

Relevance 4/10Novelty 4/10Timing: post‑market filing on Oct 20

Background

Form 4 filings disclose insider transactions; this filing reports a discretionary sale by a 10% owner.

Company-level read

Ticker impact

$TGBearishMedium confidence
Context

Insider John Gottwald sold 35,507 shares of Tredegar Corp (TG) at $8.00 each, reducing his holdings to 325,620 shares.

Expected impact

likely slight downward pressure as the market prices in the insider sell

Evidence & confidence

A $284K insider sale is modest but signals potential concern; no pre‑arranged 10b5‑1 plan suggests discretionary action.

Market effects

Minimal impact on the broader healthcare services sector.

Limited to U.S. markets where TG trades.

Insignificant.

Counterpoint

The sale size is too small to affect price; investors may ignore it.

Key entities

  • John Gottwald

    10% owner of Tredegar Corp.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TGMed

TREDEGAR REPORTS THIRD QUARTER 2026 RESULTS

TREDEGAR CORP (TG) filed an SEC Form 8-K — Results of Operations and Financial Condition. TREDEGAR REPORTS THIRD QUARTER 2026 RESULTS • Net loss from continuing operations of $(2.8) million, or $(0.08) per diluted share, for the third quarter of 2026 compared to net income from continuing operations $7.1 million, or $0.20 per diluted share, for the third quarter of 20

$TGMed

Tredegar Soars on Q2 Financials

Tredegar Corp (NYSE:TG) reported Q2 2026 results for the period ended June 30, 2026. Net income from continuing operations rose to $6.0 million, or $0.17 per diluted share, from $1.8 million, or $0.05 per share, in Q2 2025. Excluding special items, net income was $6.4 million, or $0.18 per share. Aluminum Extrusions EBITDA was $14.5 million versus $9.3 million in Q2 2025.

$TGMed

TREDEGAR REPORTS SECOND QUARTER 2026 RESULTS

TREDEGAR CORP (TG) filed an SEC Form 8-K — Results of Operations and Financial Condition. TREDEGAR REPORTS SECOND QUARTER 2026 RESULTS • Increased second quarter 2026 results, with net income from continuing operations of $6.0 million, or $0.17 per diluted share, for the second quarter of 2026 compared to $1.8 million, or $0.05 per diluted share, for the second quarte